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Abstract
Objective—Myeloid lineage cells (MLCs) such as macrophages are known to play a key role in
post-ischemic neovascularization. However, the role of MLC-derived reactive oxygen species
(ROS) in this process and the chemical identity of the ROS remain unknown.
Methods and Results—Transgenic mice with MLC-specific over-expression of catalase
(TgCat-MLC mice) were created on a C57BL/6 background. Macrophage catalase activity was
increased 3.4-fold compared to wild-type mice. After femoral artery ligation, LASER Doppler
perfusion imaging revealed impaired perfusion recovery in TgCat-MLC mice. This was associated
with fewer collateral vessels, as assessed by micro CT angiography, and decreased capillary
density. Impaired functional recovery of the ischemic limb was also evidenced by a 50% reduction
in spontaneous running activity. The deficient neovascularization was associated with a blunted
inflammatory response, characterized by decreased macrophage infiltration of ischemic tissues,
and lower mRNA levels of inflammatory markers such as tumor necrosis factor-α, osteopontin,
and matrix mettaloproteinase-9. In vitro macrophage migration was impaired in TgCat-MLC mice,
suggesting a role for H2O2 in regulating the ability of macrophages to infiltrate ischemic tissues.
Conclusions—MLC-derived H2O2 plays a key role in promoting neovascularization in response
to ischemia and is a necessary factor for the development of ischemia-induced inflammation.
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Neovascularization is an important repair mechanism to preserve tissue integrity after
ischemia, and it is a key determinant of the final outcome of vascular occlusive diseases
such as coronary or peripheral vascular atherosclerosis1, 2. The term describes a complex
process that includes the sprouting of new capillary beds (angiogenesis), the transformation
of small arterioles into large conductance arteries (collateral vessel formation, also named
arteriogenesis), and the in-situ differentiation of endothelial progenitors into mature
endothelial cells (vasculogenesis)3. In the setting of acute ischemia, it is thought that the
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largest contributor to blood flow recovery is provided by arteriogenesis in the form of
collateral arteries3. Whereas hypoxia is the major driving force in angiogenesis,
arteriogenesis seems to be more dependent on mechanical forces and inflammation4.
Previous studies have shown that myeloid lineage cells (MLCs), in particular macrophages,
play a central role in orchestrating the inflammatory response that promotes collateral vessel
growth5-8. Several factors released by macrophages, such as reactive oxygen species (ROS),
tumor necrosis factor alpha (TNF-α), osteopontin (OPN), and matrix metalloproteinases
(MMPs), among others, modulate post-ischemic neovascularization9-11.
ROS such as superoxide anion (O2·-) and hydrogen peroxide (H2O2) are key regulators of
physiological and pathophysiological responses in the vasculature. In excess amounts, ROS
are mediators of cellular injury. In contrast, at physiological levels, ROS participate in
strictly regulated redox signaling pathways, modulating cell migration, proliferation, and
matrix remodeling, all of which are necessary events for neovascularization12-15. In
addition, the proangiogenic effects of vascular growth factors such as vascular endothelial
growth factor (VEGF) and angiopoietin-1 appear to be mediated at least in part by the
production of ROS16, 17. Potential enzymatic sources of ROS in the vascular wall are
diverse and include mitochondria18, xanthine oxidase19, uncoupled nitric oxide synthase20,
and the NADPH oxidase isoforms present in a variety of cell types21, 22. In vivo studies
using knockout mice for the gp91phox subunit of NADPH oxidase show altered
neovascularization after hind limb ischemia23, thus highlighting the importance of this
particular source of ROS.
Despite the strong evidence for the role of ROS as major mediators of the angiogenic
response to ischemia, the specific ROS involved remains unclear. Compared to O2·-, H2O2
is uncharged, can diffuse freely across lipid membranes, and is longer-lived, which makes it
a good candidate for redox signaling in the vasculature. In this study we demonstrate that
H2O2 derived from inflammatory cells is an important mediator of post-ischemic
neovascularization. Using a transgenic mouse model whereby levels of H2O2 in MLCs are
decreased by the tissue-specific over-expression of catalase, we show impaired collateral
vessel formation and functional recovery of the hind limb after ischemia. This was
associated with an impaired migratory activity of catalase-overexpressing macrophages and
an overall reduced inflammatory response in the ischemic tissues.
Methods
Details are provided in an expanded Methods section in the online Data Supplement,
available at http://atvb.ahajournals.org.
Generation and Characterization of Transgenic Mice with Specific Over-expression of
Human Catalase in MLCs
To develop mice with MLC–specific over-expression of catalase (TgCat-MLC mice), we used
a Cre/LoxP system similar to that described previously24, modified to have the cre-
recombinase cDNA under the control of the MLC-specific promoter Lysz. Due to the genetic
design used, cells other than MLCs are expected to show green fluorescent protein (GFP)
fluorescence, while selective expression of cre-recombinase in MLCs will lead to excision
of the GFP gene and loss of fluorescence in this cell population (for details, please see the
online methods supplement and supplemental Figure I). All mice used in this study were on
a C57BL/6 background. Control mice used for all experiments, referred from now on as
wild type (WT) mice, were littermates of the transgenic mice. Only male mice between 8
and 10 weeks were used. All procedures were approved by the Emory University
Institutional Animal Care and Use Committee and were in compliance with the standards for
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the care and use of laboratory animals of the Institute of Laboratory Animal Resources,
National Academy of Sciences, Bethesda, MD.
The expression of human catalase and other antioxidant enzymes was assessed by western
blot of thioglycollate-induced peritoneal macrophages. Catalase activity in peritoneal
macrophages was measured as previously described24. The specificity of the cre-mediated
recombination in MLCs was assessed by immunocytochemistry of peritoneal cells and
immunohistochemistry of lung tissues as detailed in the online supplement.
Mouse Model of Unilateral Hind limb Ischemia and Assessment of Neovascularization
Ligation and excision of the left superficial femoral artery, LASER Doppler perfusion
imaging (LDPI) and micro-CT imaging were performed as previously described9. Capillary
density, expressed as number of capillaries per muscle fiber, was assessed by
immunostaining of gastrocnemius muscle against CD31and β-dystroglycan. Functional
recovery of the ischemic limb was assessed by monitoring of spontaneous activity in cages
equipped with a running wheel.
Quantification of Mobilized Endothelial Progenitor Cells (EPCs) and EPC Culture Assay
EPCs were quantified from bone marrow or peripheral blood mononuclear cells (MNCs) as
Sca-1+/Flk-1+ cells by flow cytometry. EPC culture assay was performed as previously
described25, 26.
Assessment of Inflammation in the Ischemic Hind Limb
At post-operative day 5, paraffin sections of gastrocnemius muscle were obtained and
processed for conventional hematoxylin and eosin staining or immunostaining against the
macrophages-specific marker MAC-3 or against an anti-neutrophil antibody. Levels of
CD68, OPN, TNF-α, MMP-9, VEGF and SDF-1 mRNA in gastrocnemius muscle were
measured by quantitative real-time PCR (qRT-PCR) and normalized to ribosomal 18S RNA
content.
Macrophage Migration Assay
Macrophage migration in response to MCP-1 was assessed using a modified Boyden
chamber assay as previously described9.
Measurement of H2O2 Production
H2O2 production from gastrocnemius muscle or peritoneal macrophages was measured by
Amplex Red assay (Invitrogen, Carlsbad, California) as per the manufacturer’s instructions.
Statistical Analysis
Data are presented as mean ± SEM. When applicable, values were compared by Student t
test or ANOVA with Bonferroni post-hoc analysis. p < 0.05 was considered to be
statistically significant.
Results
Phenotypic Characterization of Transgenic Mice
The expression of human catalase in MLCs of TgCat-MLC mice was evaluated by western
blot analysis of isolated peritoneal macrophages using an antibody that preferentially
identifies the human enzyme24. Figure 1A demonstrates the over-expression of human
catalase in TgCat-MLC macrophages. Other antioxidant enzyme systems were not altered
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compared to littermate WT controls (Figure 1A). To confirm that the over-expression of
catalase resulted in an increase in enzymatic activity, we assayed for catalase activity in
peritoneal macrophages. As shown in Figure 1B, TgCat-MLC macrophages exhibited a 3.4-
fold increase in catalase activity compared to WT macrophages (1169.4 ± 241.2 vs 343.1 ±
63.4 mU/mg of protein, respectively, p < 0.05).
To verify that the excision of the GFP cDNA by cre-recombinase (which allows for the
expression of the human catalase gene) was confined to MLCs, we performed
immunocytochemistry on thioglycollate-induced peritoneal cells of TgCat-MLC mice (Figure
1C), as well as immunostaining of lung sections (Figure 1D). After 72 hours of
thioglycollate injection, most peritoneal leukocytes are macrophages27. Figure 1C shows
that peritoneal cells stained for the macrophage specific antigen MAC-3 did not show GFP
fluorescence, while cells with intrinsic GFP fluorescence were not stained for MAC-3. This
absence of co-localization between GFP fluorescence and macrophage markers was also
confirmed in confocal images of lung sections where, unlike the alveolar epithelium,
resident alveolar macrophages lacked GFP (Figure 1D). These data demonstrate that human
catalase expression is indeed confined to MLCs and not present in other cell types.
Baseline characteristics before ischemia, including muscle capillary density (supplemental
Figure II) and expression of angiogenic factors such as VEGF and SDF-1 (supplemental
Figure III), were not different between genotypes. There was no obvious effect of MLC–
specific over-expression of catalase on number of total circulating leukocytes or percentages
of granulocytes, monocytes and lymphocytes (supplemental Figure IV). Similarly, no
differences in litter size, body weight, blood pressure, susceptibility to infections, or other
physical descriptors were found (data not shown).
LASER Doppler Perfusion Imaging
LDPI measurements were done from day 2 through day 28 after femoral artery ligation and
excision. The acquired images illustrated a significant lag in recovery in TgCat-MLC mice
(Figure 2A). Quantitative perfusion measurements confirmed this discrepancy (Figure 2B).
WT mice showed a steady recovery in perfusion, reaching a maximum perfusion ratio of 52
± 5% at day 28 relative to the non-ischemic leg. In contrast, TgCat-MLC mice showed a
blunted curve, which diverged from the WT curve after day 7 and reached a maximum
perfusion ratio of only 37 ± 2% at day 28 (Figure 2B, p < 0.05). The difference in perfusion
between WT and TgCat-MLC mice achieved statistical significance at day 14 and was
maintained at the subsequent time points.
Micro-CT Imaging of Collateral Vessels
Micro-CT angiography was employed to quantitatively assess vascular anatomy. Qualitative
observation of the 3-D image reconstructions of the vasculature performed 28 days after
hind limb ischemia showed reduced collateral vessel formation in TgCat-MLC mice relative
to WT (Figure 3A). Quantitative analysis of the obtained images using 3-D
histomorphometric software revealed an approximate 30% reduction in the vascular volume
to tissue volume ratio and a 15% reduction in vascular density in TgCat-MLC mice compared
to WT (Figure 3B).
Capillary Density Analysis
Capillary density was analyzed by immunohistochemistry using antibodies against CD31
and β-dystroglycan to detect endothelial cells and skeletal muscle fibers, respectively
(Figure 3C). At post-operative day 28, gastrocnemius muscle from TgCat-MLC mice showed
decreased capillary to muscle fiber ratios compared to WT (1.81 ± 0.04 vs 2.44 ± 0.16
capillaries/muscle fiber, p < 0.05, Figure 3D).
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Motor Activity Monitoring
As a physiological measure of functional ischemic limb recovery, spontaneous running
distance on an activity wheel was measured on postoperative days 28 through 35. Despite
the hind limb ischemia, WT mice exhibited a very active profile, running more than 40
kilometers over the course of a week (Figure 3E). In contrast, TgCat-MLC mice displayed
significantly decreased motor activity, as shown by a 50% reduction in total distance run
relative to WT animals (21.9 ± 6.9 vs 44.1 ± 3.9 Km, p < 0.02, Figure 3E).
EPC Mobilization and Differentiation in Response to Ischemia
To investigate whether a deficiency in EPC mobilization could contribute to the impaired
neovascularization in TgCat-MLC mice, we quantified EPCs by flow cytometry. Three days
after hind limb ischemia, we found no differences in the number of circulating EPCs in
peripheral blood or in bone marrow (supplemental Figure V). We next analyzed the
differentiation potential of peripheral blood and bone marrow MNCs into EPCs in culture,
as assessed by the uptake of acLDL and the binding of BS-1 lectin26. Despite the impaired
neovascularization in TgCat-MLC mice, there was a trend towards an increase in the number
of cultured EPCs compared to WT in peripheral blood (4.8 ± 1.0 vs 2.5 ± 0.5 cells per mm2,
respectively, p = 0.21, n = 3 per genotype) and bone marrow (167.2 ± 8.3 vs 113.6 ± 16.5
cells per mm2, respectively, p = 0.16, n = 3 per genotype).
Inflammatory Response to Ischemia
The degree of collateral vessel formation after ischemia is directly related to the
inflammatory response in the ischemic tissues3, 5, 7, 28. To assess whether the impaired
neovascularization seen in TgCat-MLC mice was associated with different levels in
inflammatory cell infiltration, we performed histological analysis of the ischemic limbs.
Hematoxylin and eosin staining of ischemic distal limbs from WT mice revealed an intense
infiltration of inflammatory cells surrounding areas of necrotic muscle fibers (Figure 4A).
Immunostaining identified macrophages as the dominant cell type (Figure 4A insert). In
contrast, TgCat-MCL mice exhibited significantly lower levels of inflammatory infiltration as
compared to WT (Figure 4A). Computer-assisted quantification of the low magnification
hematoxylin and eosin images revealed a ≈ 50% decrease in the infiltration of inflammatory
cells in TgCat-MLC mice (Figure 4B). At the same time point (post-operative day 5), the
presence of neutrophils in ischemic tissues was minimal (supplemental Figure VI).
To further assess if the difference in inflammatory cell infiltration was associated with
differential expression of inflammatory markers within the two genotypes, we performed
qRT-PCR analyses of muscle tissues. As shown in Figure 4C, mRNA levels of the
macrophage-specific marker CD68 was significantly lower in ischemic limbs of TgCat-MLC
mice compared to WT. This is consistent with the reduced number of macrophages seen on
immunohistochemistry. We also investigated the expression of other inflammatory genes
known to be involved in post-ischemic neovascularization, including TNF-α, OPN, and
MMP-99, 10, 11, 29. The up-regulation of these factors in response to ischemia was markedly
blunted in TgCat-MLC mice compared to WT (Figure 4C), such that expression was not
significantly different from the non-ischemic, control limb. A similar trend was seen for
ICAM-1 expression, although it did not reach statistical significance (data not shown). There
was no difference in VEGF mRNA or protein expression, or in SDF-1 mRNA levels,
between ischemic limbs of WT and TgCat-MLC mice (supplemental Figure VII).
Levels of H2O2 in gastrocnemius muscle were increased in the ischemic leg compared to the
non-ischemic leg in both genotypes (Figure 4D). However, there were no significant
differences in H2O2 production between WT and TgCat-MLC ischemic muscle (Figure 4D).
In contrast, and as expected by their increased catalase activity, production of H2O2 was
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lower in isolated TgCat-MLC macrophages both at baseline and after stimulation with LPS
(Figure 4E).
Macrophage Migration
Many studies have demonstrated that H2O2 plays an important role in regulating cell
migration in different cell types including vascular smooth muscle (VSMCs) and endothelial
cells (ECs)13, 30. We therefore sought to determine whether catalase over-expression by
macrophages led to changes in their migratory function. For this purpose we performed an in
vitro macrophage migration assay in a modified Boyden chamber using MCP-1 as the
chemotactic factor. Although stimulation with MCP-1 induced macrophage migration in
both genotypes compared to media alone, TgCat-MLC cells displayed a significantly impaired
migratory response compared to WT (Figure 5).
Discussion
The major finding in our study is that H2O2 derived from cells of myeloid origin plays a key
role in post-ischemic neovascularization. Transgenic mice with tissue-specific over-
expression of catalase in MLCs had impaired blood flow recovery, collateral vessel
development, capillary density, and functional capacity of the hind limb after acute
ischemia. This was associated with a blunted inflammatory response in the ischemic tissues,
characterized by lower levels of inflammatory markers and reduced macrophage infiltration.
Despite the mounting evidence for the involvement of ROS as major regulators of
neovascularization, the role of each specific ROS species, as well as the major cellular
sources responsible for their effects, remains unclear. Several animal studies on post-
ischemic neovascularization have focused on modulating O2·- levels by genetic
manipulation of Nox enzymes or superoxide dismutase isoforms23, 31, 32. Such changes in
O2·- are expected to be accompanied by changes in its dismutation product, H2O2. The role
of H2O2 in angiogenesis has been studied in vitro, where it has been shown to induce the
formation of tube-like structures by ECs33 and promote the proliferation and migration of
ECs and VSMCs13-16. However, confirmation of the angiogenic potential of H2O2 in vivo is
lacking.
Our study provides novel evidence for the role of MLC-derived H2O2 in promoting
neovascularization in vivo, as shown by the impaired perfusion recovery in TgCat-MLC mice.
The deficit in perfusion seen on LDPI analyses was explained in part by a reduction in the
number of collateral vessels formed, as assessed by micro-CT. These results are in
agreement with a previous report where, in an inverse model, catalase deficient mice form
larger arterioles in response to angiopoietin-117. Of note, while the LDPI perfusion ratios
between the ischemic and non-ischemic legs of WT mice were below 1 at 28 days, the ratios
for vascular volume obtained by micro-CT were higher than 1. This suggests the existence
of some degree of “ineffective” collateral vessel formation, consisting of non-connecting
vessels that provide abnormal perfusion to tissues.
In addition to the effects on collateral vessels, overproduction of catalase by MLCs resulted
in decreased capillary density after ischemia. The absence of differences in capillary density
in the non-ischemic muscle, along with the LDPI data showing differences in perfusion only
at later time points (after day 7), is consistent with an impairment in angiogenesis, as
opposed to differences in preexisting collaterals34.
Although O2·- has been implicated in the mobilization of EPCs after hind limb ischemia35,
we found no differences between genotypes in the number of EPCs in peripheral blood and
bone marrow after surgery, suggesting that this process is not H2O2-sensitive. Surprisingly,
Hodara et al. Page 6
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2014 January 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
there was a trend towards an increase in the number of EPCs cultured from TgCat-MLC
MNCs compared to WT. In the setting of overall impaired neovascularization, this may
represent a compensatory mechanism to overcome the deficiencies in angiogenesis and
collateral vessel formation.
Finally, and most importantly, the impaired neovascularization in TgCat-MLC mice correlated
with dramatic differences in functional recovery of the ischemic limb, as evidenced by a
50% reduction in spontaneous motor activity compared to their littermate controls.
The role of inflammation in promoting post-ischemic neovascularization, in particular
collateral vessel formation, has been well documented by numerous groups3. Macrophages
appear to play a central role in driving new vessel formation. They secrete vascular growth
factors, cytokines, MMPs, and ROS, all of which promote proliferation and migration of
vascular cells. Indeed, macrophage infiltration of ischemic tissues appears to be a necessary
event for collateral vessel development7, and it may be related to their ability to burrow
channels for vessel growth through the action of proteolytic enzymes10. Our results clearly
show a significant reduction in the inflammatory response mounted by macrophages in
TgCat-MLC mice, as evidenced by the immunohistochemistry analyses, as well as
quantification of CD68 mRNA in ischemic tissues. This correlated with decreased
expression of inflammatory markers such as OPN, TNF-α, and MMP-9; factors that have
been implicated in the formation and growth of collateral arteries9, 11. In contrast,
expression of VEGF and SDF-1 after ischemia were similar in both genotypes. Thus, these
factors did not seem to account for the observed differences in the angiogenic response.
Since H2O2 regulates cell migration in various cell types13, we hypothesized that
macrophages from TgCat-MLC mice may have an inherent deficiency in their migratory
function. Results from our in vitro migration assays are consistent with this hypothesis,
suggesting that the reduced number of infiltrating macrophages in TgCat-MLC mice is a
consequence of their impaired ability to migrate in response to an ischemic insult.
Although MLCs from TgCat-MLC mice clearly produced less H2O2 (Figure 4E), the total
amount of H2O2 released by the ischemic muscle was not significantly different than WT
(Figure 4D). Other cellular sources, such as ECs, VSMCs, or skeletal muscle fibers, may
produce enough H2O2 in response to ischemia to hinder any differences arising specifically
from MLCs. The absence of differences in global H2O2 levels in ischemic tissues raises the
possibility that H2O2 does not have a direct role in neovascularization, but acts indirectly,
perhaps by impeding the access of macrophages to the area of ischemia. However, it is also
possible that H2O2 directly regulates new vessel formation, but its actions depend on its
specific localization at the site of macrophage infiltration. Supporting this latter notion,
studies have shown that the actions of H2O2 can be localized not only as a paracrine
vascular signal36, but also within different intracellular compartments37.
A limitation of our study is posed by the relative lack of cellular specificity of the lysozyme
promoter. Although we found differences in macrophage-mediated inflammation in our
transgenic mice, it is important to point out that some activity of the promoter is expected in
other inflammatory cells of myeloid origin such as neutrophils38. These cells are known to
infiltrate tissues very early and transiently after ischemia39, but their role on post-ischemic
neovascularization is less clear, with studies showing diverse effects40, 41. In our model of
hind limb ischemia most neutrophils were absent by post-operative day 5, which is
consistent with previous reports39. At this same time point macrophage infiltration was
intense, and differences in the expression of inflammatory markers between genotypes were
significant. These findings demonstrate that H2O2 regulates macrophage-mediated
inflammatory events that are relevant to the formation of functional collateral vessels.
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Although less likely, the data do not rule out a role for neutrophil-derived H2O2 in post-
ischemic neovascularization.
Finally, studies show that different concentrations of ROS have disparate effects on
angiogenesis. For instance, in young, healthy mice, Nox2 deficiency impairs post-ischemic
neovascularization23, whereas, in older mice exposed to tobacco smoke, the same enzyme
deficiency augments post-ischemic angiogenesis32. This suggests that while some level of
ROS is necessary for neovascularization, an excess is detrimental. Indeed, the existence of
an optimal “oxidative window” was also demonstrated by Reed et al. in the coronary
circulation42. Thus, generalizing our results to conditions of increased oxidative burden
require further studies.
In summary, in this study we identify H2O2 as one of the key mediators secreted by MLCs
which regulates post-ischemic neovascularization. The mechanisms by which MLC-derived
H2O2 stimulates collateral vessel formation involve the facilitation of macrophage
infiltration in ischemic tissues and mounting of an inflammatory response. Targeting MLC-
derived H2O2 could lead to improved therapies for regulating neovascularization.
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Figure 1. MLC-specific catalase over-expression in TgCat-MLC mice
(A) Western blot analyses of peritoneal macrophages show over-expression of human
catalase in TgCat-MLC mice. Levels of superoxide dismutase (SOD)-1, SOD-2, and
glutathione peroxidase (GPx) 1/2 protein were not different from WT mice. Shown are
representative blots of three independent experiments. (B) Macrophage catalase activity was
up-regulated 3.4 fold in TgCat-MLC mice compared to WT mice. *p < 0.05. (C)
Immunocytochemistry of peritoneal cells from TgCat-MLC mice shows absence of GFP
fluoresce (green) in macrophages (red) but not in other cells types. Nuclei are stained with
DAPI (blue). (D) Merged confocal images of lung sections stained for GFP (green), alveolar
macrophages (red) and DAPI (blue). GFP fluorescence can be seen in the alveolar
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epithelium of TgCat-MLC but not in WT mice. The absence of co-localization between red
and green (yellow) indicates selective recombination of GFP in macrophages.
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Figure 2. LDPI analysis
(A) Representative LDPI images demonstrate the time course of ischemic limb reperfusion
in TgCat-MLC and WT mice. (B) Quantitative analyses are presented as perfusion ratios
(ischemic/non-ischemic leg), up to post-operative day 28. A significant lag in perfusion
recovery in TgCat-MLC mice was evident at day 14 and maintained through day 28 (n = 14 to
16 per genotype). *p < 0.05 vs WT.
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Figure 3. Analysis of collateral vessel formation, capillary density, and spontaneous motor
activity
(A) Representative Micro-CT angiographies of ischemic limbs from WT and TgCat-MLC
mice obtained at post-operative day 28. (B) Quantitative analysis showed decreased vascular
volume / tissue volume ratios as well vascular density in TgCat-MLC mice (n = 8 per
genotype). Data are expressed as fold change compared to the non-ischemic leg. *p < 0.05
vs WT. (C) Representative photomicrographs of ischemic gastrocnemius muscles stained
with antibodies against CD31 or β-dystroglycan, allowing the detection of capillaries or
muscle fibers, respectively, 28 days after surgery. Scale bar = 20 μm. (D) Quantification of
capillary density in ischemic gastrocnemius muscle of treated mice using anti-CD 31
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antibody and reported to the number of muscle fibers (n = 3 per genotype). *p < 0.05 (E)
Spontaneous motor activity recorded over a 7 day period and expressed as total distance run,
in meters. Monitoring began at post-operative day 28 (n = 6 per genotype). *p < 0.02.
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Figure 4. Inflammatory cell infiltration and expression of inflammatory markers in ischemic
tissues
(A) Representative photomicrographs of ischemic distal limbs at post-operative day 5,
stained with hematoxylin and eosin. Inserts show corresponding immunostaining for
macrophages (red). Green color represents autofluorescence from muscle fibers. Insert scale
bar = 100 μm. (B) Quantitative assessment of the basophilic areas of inflammatory cell
infiltration from hematoxylin and eosin images, expressed as percentage of total area (n = 5
per genotype). *p < 0.04. (C) mRNA levels of the corresponding inflammatory markers
were measured in ischemic and non-ischemic gastrocnemius muscle at post-operative days 5
and normalized to 18S rRNA (n = 6 per genotype). Data are expressed as fold increase
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compared to non-ischemic legs of WT mice. *p < 0.05 vs WT non-ischemic, **p < 0.05 vs
TgCat-MLC non-ischemic, §p < 0.05 vs WT ischemic. (D) H2O2 production from ischemic
and non-ischemic gastrocnemius muscle was assessed by Amplex Red assay at post-
operative day 5 (n = 3 per genotype). *p < 0.02 vs WT non-ischemic, **p < 0.02 vs
TgCat-MLC non-ischemic. (E) H2O2 production by peritoneal macrophages was assessed by
Amplex Red assay at baseline (Ctl) or after stimulation with 10 μg/mL of LPS (LPS). *p <
0.05 vs WT Ctl, **p < 0.05 vs WT + LPS.
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Figure 5. Macrophage migratory activity
Migration of isolated peritoneal macrophages in response to DMEM media alone (Ctl) or
media containing 0.5 μg/mL MCP-1. *p < 0.01 vs WT Ctl, **p < 0.01 vs TgCat-MLC Ctl, §p
< 0.02 vs WT + MCP-1.
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